common side effects of glp-1 receptor agonists Managing – Transformation Weight Control GLP-1 Receptor Agonists and Other

They cannot claim to deliver the same outcomes as FDA-approved GLP-1 drugs like Wegovy or Zepbound, Ventura tells TODAY.com

It allows for a truly personalized approach to medicine, where treatment can be tailored not just to a diagnosis, but to a patient's most important personal health goals

Hamilton Depression Rating Scale (HDRS), 23 Beck Depression Inventory (BDI), 24 and Montgomerysberg Depression Rating Scale (MADRS) 25 as standardized mean differences (SMDs) and their corresponding 95% CI at end-of-treatment (negative values favor ALC) using random-effects (REML) models

compared with placebo, treatment with GLP-1RA was associated with a 16% and 6% lower risk of MACE in patients with or without preexisting CV disease, respectively (Table 2)